$Moderate hypofractionated helical tomotherapy for older patients with localized prostate cancer: long-term outcomes of a phase I–II trial Cover$

Moderate hypofractionated helical tomotherapy for older patients with localized prostate cancer: long-term outcomes of a phase I–II trial

Radiology and Oncology

Volume 56 (2022): Issue 2 (June 2022)

By:

Di Cui, Lei Du, Wei Yu, Boning Cai, Lingling Meng, Jun Yang, Yanrong Luo, Jing Chen and Lin Ma

Open Access

|Mar 2022

DOI: https://doi.org/10.2478/raon-2022-0011 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 216 - 227

Submitted on: Aug 2, 2021

Accepted on: Feb 11, 2022

Published on: Mar 28, 2022

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 times per year

Keywords:

helical tomotherapy,

radiation dose hypofractionation,

progression-free survival,

follow-up studies,

prostatic neoplasms,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2022 Di Cui, Lei Du, Wei Yu, Boning Cai, Lingling Meng, Jun Yang, Yanrong Luo, Jing Chen, Lin Ma, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 56 (2022): Issue 2 (June 2022)Next article